These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20805742)
1. Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study. Dragun AE; Pan J; Rai SN; Kruse B; Jain D Am J Clin Oncol; 2011 Jun; 34(3):231-7. PubMed ID: 20805742 [TBL] [Abstract][Full Text] [Related]
2. Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers? Pignol JP; Rakovitch E; Olivotto IA J Clin Oncol; 2011 Jul; 29(21):2841-3. PubMed ID: 21670459 [No Abstract] [Full Text] [Related]
3. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J; J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer in very young women. Liukkonen S; Leidenius M; Saarto T; Sjöström-Mattson J Eur J Surg Oncol; 2011 Dec; 37(12):1030-7. PubMed ID: 21937191 [TBL] [Abstract][Full Text] [Related]
6. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors. Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181 [TBL] [Abstract][Full Text] [Related]
7. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer. Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819 [TBL] [Abstract][Full Text] [Related]
8. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study]. Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Morcos B; Jaradat I; El-Ghanem M Eur J Surg Oncol; 2011 May; 37(5):418-21. PubMed ID: 21316187 [TBL] [Abstract][Full Text] [Related]
10. Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer. Vargo JA; Beriwal S; Ahrendt GM; Soran A; Johnson RR; McGuire K; Bhargava R Oncology; 2011; 80(5-6):341-9. PubMed ID: 21791944 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of breast cancer patients with triple negative receptor status treated with accelerated partial breast irradiation. Wilkinson JB; Reid RE; Shaitelman SF; Chen PY; Mitchell CK; Wallace MF; Marvin KS; Grills IS; Margolis JM; Vicini FA Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e159-64. PubMed ID: 21345613 [TBL] [Abstract][Full Text] [Related]
12. Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status. Wilder RB; Curcio LD; Khanijou RK; Eisner ME; Kakkis JL; Chittenden L; Agustin J; Lizarde J; Mesa AV; Macedo JC; Ravera J; Tokita KM Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):799-803. PubMed ID: 20869583 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy. Selz J; Stevens D; Jouanneau L; Labib A; Le Scodan R Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1123-32. PubMed ID: 22572073 [TBL] [Abstract][Full Text] [Related]
14. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. Haffty BG; Yang Q; Reiss M; Kearney T; Higgins SA; Weidhaas J; Harris L; Hait W; Toppmeyer D J Clin Oncol; 2006 Dec; 24(36):5652-7. PubMed ID: 17116942 [TBL] [Abstract][Full Text] [Related]
15. Negative margin status improves local control in conservatively managed breast cancer patients. Obedian E; Haffty BG Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736 [TBL] [Abstract][Full Text] [Related]
16. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction. Kneubil MC; Brollo J; Botteri E; Curigliano G; Rotmensz N; Goldhirsch A; Lohsiriwat V; Manconi A; Martella S; Santillo B; Petit JY; Rietjens M Eur J Surg Oncol; 2013 Mar; 39(3):260-5. PubMed ID: 23313014 [TBL] [Abstract][Full Text] [Related]
18. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy. Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572 [TBL] [Abstract][Full Text] [Related]
19. Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy. Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1095-101. PubMed ID: 20638197 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of osteopontin in patients with triple-negative breast cancer. Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]